Metro Healthcare Bhd (XKLS:0329) Piotroski F-Score: 7 (As of Jul. 05, 2026) — 133% Above Median


XKLS:0329 Metro Healthcare Bhd XKLS:0329
59 GF Score
Price RM0.22
GF Value RM0.32
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Metro Healthcare Bhd Piotroski F-Score?

Metro Healthcare Bhd XKLS:0329 59 Piotroski F-Score is 7 as of Jul. 05, 2026, which is 133% above its 10-year median of 3.00. GuruFocus rates XKLS:0329 with a GF Score™ of 59/100 and a GF Value™ of RM0.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 649 Healthcare Providers & Services companies, Metro Healthcare Bhd ranks better than 88.91% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Metro Healthcare Bhd has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Metro Healthcare Bhd's Piotroski F-Score or its related term are showing as below:

XKLS:0329' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 9
Current: 7

During the past 11 years, the highest Piotroski F-Score of Metro Healthcare Bhd was 9. The lowest was 1. And the median was 3.

Metro Healthcare Bhd  (XKLS:0329) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Metro Healthcare Bhd Piotroski F-Score Related Terms


Metro Healthcare Bhd Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Metro Healthcare Bhd's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metro Healthcare Bhd Piotroski F-Score Chart

Metro Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 2.00 1.00 5.00 9.00

Metro Healthcare Bhd Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 7.00 7.00 9.00 7.00

XKLS:0329 vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Metro Healthcare Bhd's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metro Healthcare Bhd Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Metro Healthcare Bhd's Piotroski F-Score falls into.


XKLS:0329
59GF Score
Metro Healthcare Bhd XKLS:0329
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 1.204 + 2 + 2.226 + 1.001 = RM6.43 Mil.
Cash Flow from Operations was 2.924 + 4.858 + 1.914 + 1.746 = RM11.44 Mil.
Revenue was 12.63 + 13.129 + 13.535 + 11.227 = RM50.52 Mil.
Gross Profit was 4.716 + 5.089 + 5.748 + 3.484 = RM19.04 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(95.759 + 93.766 + 93.381 + 92.525 + 100.792) / 5 = RM95.2446 Mil.
Total Assets at the begining of this year (Mar25) was RM95.76 Mil.
Long-Term Debt & Capital Lease Obligation was RM16.26 Mil.
Total Current Assets was RM61.97 Mil.
Total Current Liabilities was RM8.24 Mil.
Net Income was 0 + 1.5 + -0.474 + 0.306 = RM1.33 Mil.

Revenue was 0 + 12.294 + 11.872 + 11.121 = RM35.29 Mil.
Gross Profit was 0 + 4.694 + 4.294 + 3.406 = RM12.39 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Mar25) was
(59.778 + 57.886 + 57.783 + 96.032 + 95.759) / 5 = RM73.4476 Mil.
Total Assets at the begining of last year (Dec23) was RM59.78 Mil.
Long-Term Debt & Capital Lease Obligation was RM13.54 Mil.
Total Current Assets was RM60.77 Mil.
Total Current Liabilities was RM5.65 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Metro Healthcare Bhd's current Net Income (TTM) was 6.43. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Metro Healthcare Bhd's current Cash Flow from Operations (TTM) was 11.44. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=6.431/95.759
=0.06715818

ROA (Last Year)=Net Income/Total Assets (Dec23)
=1.332/59.778
=0.02228245

Metro Healthcare Bhd's return on assets of this year was 0.06715818. Metro Healthcare Bhd's return on assets of last year was 0.02228245. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Metro Healthcare Bhd's current Net Income (TTM) was 6.43. Metro Healthcare Bhd's current Cash Flow from Operations (TTM) was 11.44. ==> 11.44 > 6.43 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=16.26/95.2446
=0.17071834

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Mar25
=13.539/73.4476
=0.1843355

Metro Healthcare Bhd's gearing of this year was 0.17071834. Metro Healthcare Bhd's gearing of last year was 0.1843355. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=61.971/8.237
=7.52349156

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=60.772/5.653
=10.75039802

Metro Healthcare Bhd's current ratio of this year was 7.52349156. Metro Healthcare Bhd's current ratio of last year was 10.75039802. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Metro Healthcare Bhd's number of shares in issue this year was 978.905. Metro Healthcare Bhd's number of shares in issue last year was 978.905. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=19.037/50.521
=0.3768136

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=12.394/35.287
=0.35123417

Metro Healthcare Bhd's gross margin of this year was 0.3768136. Metro Healthcare Bhd's gross margin of last year was 0.35123417. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=50.521/95.759
=0.52758487

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=35.287/59.778
=0.59030078

Metro Healthcare Bhd's asset turnover of this year was 0.52758487. Metro Healthcare Bhd's asset turnover of last year was 0.59030078. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Metro Healthcare Bhd has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Metro Healthcare Bhd (XKLS:0329) has a Piotroski F-Score of 7 as of Jul. 05, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Metro Healthcare Bhd and its competitors. This is 133% above median its historical median of 3.00. Over the past decade, Metro Healthcare Bhd's Piotroski F-Score has ranged from 1.00 to 9.00. According to the industry distribution chart, Metro Healthcare Bhd ranks #72 out of 649 companies in the Healthcare Providers & Services industry, placing it in the top 11.1%.
Is Metro Healthcare Bhd's Piotroski F-Score too high?
Metro Healthcare Bhd's current Piotroski F-Score of 7 is 133% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 9.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Metro Healthcare Bhd's value of 7 is 40% above this industry median. Based on the distribution chart, Metro Healthcare Bhd ranks #72 out of 649 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Metro Healthcare Bhd has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Metro Healthcare Bhd ranks #72 out of 649 companies for Piotroski F-Score. This places Metro Healthcare Bhd in the top 11% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Metro Healthcare Bhd's value of 7 is 40% above this benchmark. Historically, Metro Healthcare Bhd's own Piotroski F-Score has ranged from 1.00 to 9.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, Metro Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 649 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metro Healthcare Bhd's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Metro Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metro Healthcare Bhd's current Piotroski F-Score is 7, which is 133% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.32, compared to a current price of RM0.22 — trading 32.8% below its estimated fair value. The current Piotroski F-Score is 7, which is 133% above median its 10-year median of 3.00 and 40% above the Healthcare Providers & Services industry median of 5.00. Metro Healthcare Bhd's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current Piotroski F-Score is 7 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?

Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued. The current stock price of RM0.22 is trading 32.8% below its estimated GF Value™ of RM0.32. GuruFocus considers Metro Healthcare Bhd to be Possible Value Trap.

Key valuation signals for XKLS:0329:

  • Piotroski F-Score: 7 (133% above median its 10-year median of 3.00)
  • GF Value™: RM0.32 vs. price of RM0.22 (32.8% below fair value)
  • GF Score™: 59/100 with 4 warning signs
  • Industry Position: 40% above the Healthcare Providers & Services median (#72 of 649)

No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Metro Healthcare Bhd Business Description

Address No. 32, Jalan Pasar, Klang, SGR, MYS, 41400
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
59GF Score

Get the complete analysis for XKLS:0329

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.22
Price
RM0.32
GF Value